Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Stacey M Anderson"'
Autor:
Boris P Kovatchev, ProfPhD, Laura Kollar, RN, Stacey M Anderson, MD, Charlotte Barnett, BA, Marc D Breton, PhD, Kelly Carr, MA, Rachel Gildersleeve, BA, Mary C Oliveri, MS, Christian A Wakeman, MS, Sue A Brown, MD
Publikováno v:
The Lancet: Digital Health, Vol 2, Iss 2, Pp e64-e73 (2020)
Summary: Background: Automated closed-loop control delivery of insulin, also known as the artificial pancreas, is emerging as a treatment option for type 1 diabetes, which is considered generally superior to sensor-augmented insulin pump therapy. Eve
Externí odkaz:
https://doaj.org/article/91b53be565e24330a37f445768e70200
Autor:
Leon S Farhy, Alice eChan, Marc D Breton, Stacey M Anderson, Boris P Kovatchev, Anthony L McCall
Publikováno v:
Frontiers in Physiology, Vol 3 (2012)
Glucagon Counterregulation (GCR) protects against hypoglycemia, but is impaired in type 1 diabetes (T1DM). A model-based analysis of in vivo animal data predicts that the GCR defects are linked to basal hyperglucagonemia. To test this hypothesis we s
Externí odkaz:
https://doaj.org/article/da389de1441745aea4759bdab1c25c8a
Autor:
Thibault Gautier, Sue A. Brown, Mary Clancy-Oliveri, Daniel R. Cherñavvsky, Jessica Robic, Stacey M. Anderson, Marc D. Breton, Mark D. DeBoer, Melissa J Schoelwer, Kelly Carr, Chiara Fabris
Publikováno v:
Diabetes Technology & Therapeutics. 22:594-601
Objective: To assess the safety and efficacy of a simplified initialization for the Tandem t:slim X2 Control-IQ hybrid closed-loop system, using parameters based on total daily insulin (“MyTDI”) in...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d3dd15e951636b470a08d18319de53
https://doi.org/10.1089/dia.2019.0471
https://doi.org/10.1089/dia.2019.0471
Autor:
Mary C. Oliveri, Marc D. Breton, Stacey M. Anderson, Charlotte L. Barnett, Kelly Carr, Daniel R. Cherñavvsky, Ralf Nass, Jennifer Pinnata, Chaitanya L.K. Koravi, Chiara Fabris
Publikováno v:
Diabetes Care
OBJECTIVE Insulin dosing in type 1 diabetes (T1D) is oftentimes complicated by fluctuating insulin requirements driven by metabolic and psychobehavioral factors impacting individuals’ insulin sensitivity (IS). In this context, smart bolus calculato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f95a83bba9097b721755c1f1e9a065
https://doi.org/10.2337/dc19-1675
https://doi.org/10.2337/dc19-1675
Autor:
Selassie Ogyaadu, Stacey M. Anderson, Liana Hsu, David W. Lam, Grenye O’Malley, Laya Ekhlaspour, Bruce A. Buckingham, Jessica Robic, Camilla Levister, Lisa M. Norlander, Alessandro Bisio, Carol J. Levy, Marc D. Breton
Publikováno v:
Diabetes Care
OBJECTIVE Achieving optimal glycemic control for many individuals with type 1 diabetes (T1D) remains challenging, even with the advent of newer management tools, including continuous glucose monitoring (CGM). Modern management of T1D generates a weal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1df61735deb71cab133b15a6c869494c
https://doi.org/10.2337/figshare.16891267
https://doi.org/10.2337/figshare.16891267
Autor:
Christian A. Wakeman, Liana J Hsu, Sue A. Brown, Bruce A. Buckingham, Trang T. Ly, Jessica Robic, Stacey M. Anderson, Mary C. Oliveri, Lisa M. Norlander, Charlotte L. Barnett, Sarah E. Loebner, Boris Kovatchev, Marc D. Breton, Ryan S. Kingman, Paula Clinton, Suzette Reuschel-DiVirglio
Publikováno v:
Diabetes Technol Ther
Background: Typically, closed-loop control (CLC) studies excluded patients with significant hypoglycemia. We evaluated the effectiveness of hybrid CLC (HCLC) versus sensor-augmented pump (SAP) in reducing hypoglycemia in this high-risk population. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7069415dfd64c7d08ea13d5abea04189
https://doi.org/10.1089/dia.2019.0018
https://doi.org/10.1089/dia.2019.0018
Autor:
iDCL Trial Research Group, John W. Lum, Craig Kollman, Marc D. Breton, Vinaya Simha, Camilla Levister, Gregory P. Forlenza, Laya Ekhlaspour, Mei Mei Church, Stacey M. Anderson, Louise Ambler-Osborn, Francis J. Doyle III, Eyal Dassau, Jordan E. Pinsker, Carol J. Levy, Yogish C. Kudva, R. Paul Wadwa, Lori M. Laffel, Bruce A. Buckingham, Dan Raghinaru, Roy W. Beck, Sue A. Brown
Background: Limited information is available about glycemic outcomes with closed-loop control (CLC) compared with predictive-low glucose suspend (PLGS). Methods: After 6 months of use of a CLC system in a randomized trial, 109 participants with type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12e5d9d0974083caba43f6cba3478a5f
https://doi.org/10.2337/figshare.12240968.v1
https://doi.org/10.2337/figshare.12240968.v1
Autor:
Sue A, Brown, Roy W, Beck, Dan, Raghinaru, Bruce A, Buckingham, Lori M, Laffel, R Paul, Wadwa, Yogish C, Kudva, Carol J, Levy, Jordan E, Pinsker, Eyal, Dassau, Francis J, Doyle, Louise, Ambler-Osborn, Stacey M, Anderson, Mei Mei, Church, Laya, Ekhlaspour, Gregory P, Forlenza, Camilla, Levister, Vinaya, Simha, Marc D, Breton, Craig, Kollman, John W, Lum, Boris P, Kovatchev, Thomas, Eggerman
Publikováno v:
Diabetes Care
OBJECTIVE Limited information is available about glycemic outcomes with a closed-loop control (CLC) system compared with a predictive low-glucose suspend (PLGS) system. RESEARCH DESIGN AND METHODS After 6 months of use of a CLC system in a randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a005c264344631d9b9c278b93f0cd2b6
https://pubmed.ncbi.nlm.nih.gov/32471910
https://pubmed.ncbi.nlm.nih.gov/32471910
Autor:
Ananda Basu, Michele Schiavon, Tyler Jean, Steve Patek, Alejandro J. Laguna Sanz, Mei Mei Church, Jordan E. Pinsker, Boris Kovatchev, Ling Hinshaw, Vikash Dadlani, Stacey M. Anderson, Francis J. Doyle, Wendy C. Bevier, Shelly K. McCrady-Spitzer, Elaine Schertz, Rickey E. Carter, Yogish C. Kudva, Dayu Lv, Paige K. Bradley, Emma Emory, Claudio Cobelli, Chiara Dalla Man, Ravi Gondhalekar, Jonathan Hughes, Eyal Dassau, Isuru Dasanayake, Lauren M. Huyett, Sue A. Brown
Publikováno v:
Diabetes Care. 40:1719-1726
OBJECTIVE Artificial pancreas (AP) systems are best positioned for optimal treatment of type 1 diabetes (T1D) and are currently being tested in outpatient clinical trials. Our consortium developed and tested a novel adaptive AP in an outpatient, sing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67b3d9cf252d5f86ad1e074bb4dcb9d9
https://doi.org/10.2337/dc17-1188
https://doi.org/10.2337/dc17-1188
Publikováno v:
Journal of Diabetes Science and Technology. 12:311-317
Aims: In type 1 diabetes (T1D), repeated hypoglycemic episodes may reduce hormonal defenses and increase the risk for severe hypoglycemia. In this work, we investigate the effect of a structured hyper/hypoglycemic metabolic challenge on the postinter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f4c0c770b47defaead234e59d54ac6
https://doi.org/10.1177/1932296817729392
https://doi.org/10.1177/1932296817729392